PARP Inhibitor PJ34 Protects Mitochondria and Induces DNA-Damage Mediated Apoptosis in Combination With Cisplatin or Temozolomide in B16F10 Melanoma Cells

PARP-1 inhibition has recently been employed in both mono- and combination therapies in various malignancies including melanoma with both promising and contradicting results reported. Although deeper understanding of the underlying molecular mechanisms may help improving clinical modalities, the com...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Physiol
Main Authors: Cseh, Anna Maria, Fabian, Zsolt, Quintana-Cabrera, Ruben, Szabo, Aliz, Eros, Krisztian, Soriano, Maria Eugenia, Gallyas, Ferenc, Scorrano, Luca, Sumegi, Balazs
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2019
Teme:
Physiology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6514236/
https://ncbi.nlm.nih.gov/pubmed/31133874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphys.2019.00538
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki